Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3976509 | Brachytherapy | 2015 | 8 Pages |
Abstract
This patient subset had background characteristics very similar to those of the COMS and patients treated at our institution with I-125 plaques. Treatment response was equivalent although radiation complications occurred slightly less frequently in the Ru-106 group compared with those treated with I-125. Image-guided three-dimensional pretreatment modeling for plaque localization and dosimetry seems to work equally as well for Ru as for I-125 plaques and justifies more extensive investigation.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Andrew W. Browne, Savita V. Dandapani, Richard Jennelle, Marta Stevanovic, Thomas C. Lee, A. Linn Murphree, Thomas D. Kampp, Melvin A. Astrahan, Jonathan W. Kim, Jesse L. Berry,